Clearside Biomedical CLSD reported its Q1 earnings results on Thursday, May 11, 2023 at 07:05 AM.
Here's what investors need to know about the announcement.
Earnings
Clearside Biomedical missed estimated earnings by 7.14%, reporting an EPS of $-0.15 versus an estimate of $-0.14.
Revenue was down $343 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.03 which was followed by a 9.24% drop in the share price the next day.
Here's a look at Clearside Biomedical's past performance:
Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
---|---|---|---|---|
EPS Estimate | -0.13 | -0.03 | -0.13 | -0.08 |
EPS Actual | -0.16 | -0.13 | -0.13 | -0.13 |
Revenue Estimate | 100K | 6.52M | 370K | 2.87M |
Revenue Actual | 330K | 266K | 384K | 347K |
To track all earnings releases for Clearside Biomedical visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.